Back to search

Article

Plasma exosome microRNA-155-3p expression in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors: a potential biomarker of response to systemic therapy

2023-12-06

Abstract excerpt

Predictive biomarkers of response to immune checkpoint-based therapies (ICI) remain a critically unmet need in the management of advanced renal cell carcinoma (RCC). The complex interplay of the tumour microenvironment and components of the circulating immune response has proven to be challenging to decipher. MicroRNAs have gained increasing attention for their role in post-transcriptional gene expression regulati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b0cbda2f-fc45-5f28-b33e-e0725b79bb53
DOI
10.21203/rs.3.rs-3674769/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasma exosome microRNA-155-3p expression in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors: a potential biomarker of response to systemic therapyDOI 10.21203/rs.3.rs-3674769/v1
Select a neighboring publication to make it the new centre.